CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Vitreoject UG aims to enhance eye care access by revolutionizing the injection process for age-related macular degeneration. Their innovative device integrates all necessary components into one efficient and safe system, significantly improving the procedure while reducing healthcare costs.
Dr Kromer and Mr Dabous founded Vitreoject UG (limited liability) in Hamburg in 2018.
Togetherwith our team, we aim to increase access to eye care by improving and optimising process operations.Age-related macular degeneration is the leading cause of visual impairment in the elderlyand treated with medication injected into the eye.
Before the introduction of the drug, lessthan 5,000 injections were administered annually.
Since then, global numbers rose to more than 90million worldwide.
However,…
VITREOJECT UG (HAFTUNGSBESCHRANKT)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
